We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Hemogenyx Pharmaceuticals Plc | LSE:HEMO | London | Ordinary Share | GB00BYX3WZ24 | ORD GBP0.01 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.0025 | -0.14% | 1.76 | 1.73 | 1.76 | 1.75 | 1.73 | 1.74 | 7,822,292 | 16:35:08 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Finance Services | 0 | -3.98M | -0.0035 | -4.97 | 19.87M |
Date | Subject | Author | Discuss |
---|---|---|---|
22/2/2020 23:30 | Johntopdog = Spam poster | marie1980 | |
22/2/2020 21:47 | Spam poster !! | johntopdog | |
22/2/2020 20:52 | last chance.post sensibly please. | purple11 | |
22/2/2020 13:02 | Vladislav Sandler@vmsandler·14 | tsmith2 | |
22/2/2020 10:47 | impatient daytraders and placee flippers over reacted bringing this down after this fasntastic news.expecting price to firm up over coming days. if the placees are going to flip all their stock we may remain weak for a while. that will pass and there will be better days ahead. | purple11 | |
22/2/2020 10:44 | Hemogenyx Reports Positive Test Results From Cancer Therapy Treatment (Alliance News) - Hemogenyx Pharmaceuticals PLC on Thursday said testing of the company's cancer ... Alliance News 20 February, 2020 | 3:15PM (Alliance News) - Hemogenyx Pharmaceuticals PLC on Thursday said testing of the company's cancer therapy HEMO-CAR-T has yielded positive results and additional engineering may improve the safety and versatility of the therapy. The company's Chimeric Antigen Receptor programmed T cells therapy is used for the treatment of acute myeloid leukemia. The therapy is a treatment in which a patient's own T cells, a type of immune cell, are modified to recognise and kill the patient's cancer cells. Hemogenyx said in-vivo testing of the therapy has indicated anti-cancer activity in a mouse model, with the therapy able to identify and destroy cancer cells. The company is additionally undertaking further engineering of HEMO-CAR therapy to enhance the activity of the technology. It is introducing and testing a safety switch within the HEMO-CAR technology to control the level of activity of HEMO-CAR-T cells. "The purpose of these efforts is to dramatically improve the safety and potential versatility of HEMO-CAR-T cells for the treatment of acute myeloid leukemia and/or conditioning of bone marrow transplants, as well as a number of additional potential indications," Hemogenyx said. Vladislav Sandler, chief executive officer, said: "We are encouraged by this new data which demonstrates our continuing progress in the development of novel treatments for blood cancers such as AML. The development of HEMO-CAR-T cells expands Hemogenyx's pipeline and advances it into a cutting-edge area of cell-based immune therapy." Hemogenyx shares were up 5.3% at 1.98 pence each in London on Thursday afternoon. | purple11 | |
22/2/2020 10:40 | tweeted an hr after hemogenyx tweeted Morningstar coverage of cart in vivo results.could be linked or wonder what hes tweeting about?dare I see development agreement has been signed? Vladislav Sandler @vmsandler · 11h Almost everyone has a few special days that change the course of their lives. Today was one of those days in my #life. Dreams do come true. | purple11 | |
21/2/2020 17:54 | Ignore that spam link | 1savvyinvestor | |
21/2/2020 17:07 | Do not let feelings guide you. Look at the achievements of the company. | scaramouche1941 | |
21/2/2020 17:05 | Do we know who the share placing went to?....presumably individuals as there was no TR1 | johntopdog | |
21/2/2020 16:27 | today I feel like a chump. one day I may feel like a genius. | purple11 | |
21/2/2020 16:19 | Let's hope there's a train coming soon then! | flashheart | |
21/2/2020 16:19 | So much for this hope then: "Sir Marc Feldman, Chairman, commented, "...We welcome our new shareholders on board in the hope that they share and participate in the Company's future development and success." I'm surprised that placees aiming for a quick in-and-out would go for a stock like this though, which isn't exactly super-liquid? I guess we can blame the broker for placing to idiots? | on target | |
21/2/2020 16:17 | fortunately 'she's' found some playmates on metro to keep her occupied | elpirata |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions